<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D"><gtr:id>20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D</gtr:id><gtr:name>International Stem Cell Forum (ISCF)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Molecular Biology and Biotechnology</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D"><gtr:id>20A7D9B9-9D83-49FA-9E48-AB596B9E1D7D</gtr:id><gtr:name>International Stem Cell Forum (ISCF)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CDF99109-6551-4702-82BE-688365A28487"><gtr:id>CDF99109-6551-4702-82BE-688365A28487</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Moore</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801059"><gtr:id>DD7DE629-7D42-4EF9-A34A-4DB3898B3435</gtr:id><gtr:title>Derivation of clinical grade human embryonic stem cell lines for therapeutic applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801059</gtr:grantReference><gtr:abstractText>In future it might be possible to use stem cells to treat diseases for which we currently have no cure. These include, heart disease (the biggest killer in the UK), Juvenile (type 1) diabetes, and degenerative neurological conditions such as Parkinson s and Motor Neurone disease. But before we can test potential therapies on patients we must create cell lines that are safe (free of infectious agents and possible animal contamination) and genetically stable. At the moment embryonic stem cells can only be used for reseach. This project aims to efficently produce embryonic stem cells to laboratory standards (called Good Manufacturing Practice, GMP) that allow them to be used for treatment of patients. The cell lines will be deposited in the UK Stem Cell Bank and will be freely available to the medical community.</gtr:abstractText><gtr:technicalSummary>A major barrier to the progress of using human embryonic stem cells (hESCs) for regenerative medicine is the efficient generation of cell lines to a grade suitable for producing differentiated cell types to administer to patients in clinical trials. The production of such cell lines requires compliance to standards of Good Manufacturing Practice (GMP) and must therefore meet stringent ethical and quality assurance criteria to comply with regulations that govern clinical trials in the UK under the EU Tissue and Cell Directive (EUTCD, 2006). The latter creates a common framework that ensures high standards in the procurement, testing, processing, storage, distribution and import / export of tissues and cells across the EU community. The FDA sets an equivalent standard in North America. We have established a stem cell derivation facility, embryo network and validated protocols to meet this need and here propose to generate a minimum of five master banks of clinical grade cell lines. Our previous record in generating research hESC lines would indicate that we are likely to readily exceed this quota and produce 10 ?15 clinical grade lines over three years. The lines will be deposited with the UK Stem Cell Bank (UKSCB) for distribution to the medical community and used also to advance our ongoing collaborative research programmes to develop applications for macular eye disease and immune tolerised coronary stents to the stage of phase I/II clinical trials within the next two years.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1401306</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Stem Cell Forum (ISCF)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>International Stem Cell Initiative</gtr:department><gtr:description>International Stem cell Initiative</gtr:description><gtr:id>1E21222E-1543-4629-94E9-E23BFC911F9E</gtr:id><gtr:impact>PMID: 17572666</gtr:impact><gtr:outcomeId>3A3FF5043AA-1</gtr:outcomeId><gtr:partnerContribution>Providing data on stem cell lines</gtr:partnerContribution><gtr:piContribution>Data and cell line samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Development of hES cell lines to GMP standard</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>288B341E-6BB3-4099-B222-3BD5155A007D</gtr:id><gtr:impact>poster at ISCCR stem cell conference by Dr Z. Hewitt

inititated collaborative talks with other groups</gtr:impact><gtr:outcomeId>00B44E48A48</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Stem Cell liaison/UK Stem Cell forum</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>64D488C2-43EB-47F7-956C-D1ABD6BD3288</gtr:id><gtr:impact>Meretings to get consensus in the filed and advise policy makers including ethical aspects

Input into HFE act related to embryonic stem cells Input into policy of regulators such as HTA MHRA</gtr:impact><gtr:outcomeId>E9C89683FCD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Training courses</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>06D7BA96-3259-4AD8-85F7-70C5EA90A1E7</gtr:id><gtr:impact>A 3 day course on the practise of the culture of human embryonic stem cells

Development of standard protocols for human embryonic stem cells</gtr:impact><gtr:outcomeId>EBD0EDA1A91</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Procedures for producinh embryonic stem cells to GMP</gtr:description><gtr:grantRef>G0801059</gtr:grantRef><gtr:id>7B89FE3F-77FF-4AFE-9FC3-A8A1B88009C1</gtr:id><gtr:impact>commercial collaborations</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>4CA37898091</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>GMP standard operating procedures</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Characterisation of human cells for clinical applications. (2011) British Standards Institute, PAS 93:2011</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C29A626B-FAF2-4781-83DA-BD8286CCC30F</gtr:id><gtr:impact>guidelines for clinical grade stem cell production by British Standards Institute</gtr:impact><gtr:outcomeId>HkBFxvX2YFm</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Practical Training for human embryonic stem cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>531632F3-C129-4B60-99CA-EB1050506B01</gtr:id><gtr:impact>Our course format adopted by others</gtr:impact><gtr:outcomeId>3F8425FD6AA</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Commercialisation of stem cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>7F767304-E9B7-4315-B9A0-DDDFDCF034CD</gtr:id><gtr:impact>input into guidelines related to use of human embryonic stem cells at National level</gtr:impact><gtr:outcomeId>01DCAB2B7DC</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9F02C4F4-6566-4F3D-AA11-E786B0829912</gtr:id><gtr:title>Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ff671f2b1b1e82eef47877074505c5"><gtr:id>c2ff671f2b1b1e82eef47877074505c5</gtr:id><gtr:otherNames>Su?rez-Alvarez B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>f1E6htxzpMb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78979DD8-E670-470A-ABF8-2107EAC0C06F</gtr:id><gtr:title>Human fetal auditory stem cells can be expanded in vitro and differentiate into functional auditory neurons and hair cell-like cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699ec640b1c8da6802ba2f100373f8e1"><gtr:id>699ec640b1c8da6802ba2f100373f8e1</gtr:id><gtr:otherNames>Chen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>754CF94A501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82FDD1E3-AC4B-48E6-A725-441836AB044E</gtr:id><gtr:title>Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7d39b148bebd378006c2b425ce30449"><gtr:id>e7d39b148bebd378006c2b425ce30449</gtr:id><gtr:otherNames>Aflatoonian B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>T2WJ8bA5JjZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00A00A52-5F1C-4C7A-8549-AD84D5C13C00</gtr:id><gtr:title>Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5595022016a4a1c3f702d2689191724"><gtr:id>a5595022016a4a1c3f702d2689191724</gtr:id><gtr:otherNames>Furue MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>B89B0700149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EDDEE1E-7199-4EC7-B0E0-69423D4EC6AD</gtr:id><gtr:title>In situ cryopreservation of human embryonic stem cells in gas-permeable membrane culture cassettes for high post-thaw yield and good manufacturing practice.</gtr:title><gtr:parentPublicationTitle>Cryobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1ab453b42490ccac7de3a8c795f7594"><gtr:id>d1ab453b42490ccac7de3a8c795f7594</gtr:id><gtr:otherNames>Amps KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0011-2240</gtr:issn><gtr:outcomeId>g5uCTuqPomy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91EEDC3D-AA00-41F9-BA20-0B4E45868900</gtr:id><gtr:title>Telomeric NAP1L4 and OSBPL5 of the KCNQ1 cluster, and the DECORIN gene are not imprinted in human trophoblast stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6292bd03d54f0f6770ebda5bc7b9abd6"><gtr:id>6292bd03d54f0f6770ebda5bc7b9abd6</gtr:id><gtr:otherNames>Frost JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>cwRSVPXCLeU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AE91EBD-80E5-43F5-BC0A-3C3407DF8092</gtr:id><gtr:title>Pinacidil enhances survival of cryopreserved human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Cryobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3794ab5d3cad9801078c60433623947"><gtr:id>a3794ab5d3cad9801078c60433623947</gtr:id><gtr:otherNames>Barbaric I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0011-2240</gtr:issn><gtr:outcomeId>JefX2stWD45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D934B97-B2BA-490E-A3C3-EA28C2D9B7DF</gtr:id><gtr:title>In vitro post-meiotic germ cell development from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7d39b148bebd378006c2b425ce30449"><gtr:id>e7d39b148bebd378006c2b425ce30449</gtr:id><gtr:otherNames>Aflatoonian B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>FCA81CF513E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A5789A6-8F72-4A94-949F-20F0F25EA974</gtr:id><gtr:title>Restoration of auditory evoked responses by human ES-cell-derived otic progenitors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699ec640b1c8da6802ba2f100373f8e1"><gtr:id>699ec640b1c8da6802ba2f100373f8e1</gtr:id><gtr:otherNames>Chen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15409_29_22972191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23657392-4908-4895-869F-18A666371F97</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_15409_29_22119741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15475D3A-09B9-4FA0-99BD-D3EDBA951C5A</gtr:id><gtr:title>Endoplasmic reticulum stress signals in defined human embryonic stem cell lines and culture conditions.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cd46ac82bfb660f8c87c3cfe2f3f95f"><gtr:id>9cd46ac82bfb660f8c87c3cfe2f3f95f</gtr:id><gtr:otherNames>Blanco-Gelaz MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>rZ3oHvC7dDD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BCB1683-7A1E-4192-9002-C172298414EC</gtr:id><gtr:title>CD133-enriched Xeno-Free human embryonic-derived neural stem cells expand rapidly in culture and do not form teratomas in immunodeficient mice.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95fbcc4dd5541891282568bf81de9b0d"><gtr:id>95fbcc4dd5541891282568bf81de9b0d</gtr:id><gtr:otherNames>Haus DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>544fa6ab840947.93355790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>019828BD-32A6-4CBB-87B1-39C5B5F0AD0B</gtr:id><gtr:title>Generation of T cells from human embryonic stem cell-derived hematopoietic zones.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3415583be7b0b07a9704b0aeebee6eb7"><gtr:id>3415583be7b0b07a9704b0aeebee6eb7</gtr:id><gtr:otherNames>Timmermans F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>AFFC7795EA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68ACDF99-002E-41E4-A62F-CB40B9652B2C</gtr:id><gtr:title>Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay.</gtr:title><gtr:parentPublicationTitle>Molecular vision</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c73f01c778c6ba0f5bf0ad99ad99008"><gtr:id>6c73f01c778c6ba0f5bf0ad99ad99008</gtr:id><gtr:otherNames>Carr AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1090-0535</gtr:issn><gtr:outcomeId>C86B883F1C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>029BC899-4991-4A4B-B0DB-CF708DDDCAFC</gtr:id><gtr:title>Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/725d10cb4b6c32ad5dbbb3f255c3d022"><gtr:id>725d10cb4b6c32ad5dbbb3f255c3d022</gtr:id><gtr:otherNames>Zafarana G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>D3F66856669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F13F65FB-C283-4642-968C-D3C8A2CD564D</gtr:id><gtr:title>Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf0abb788987e35a66848692891f17f"><gtr:id>edf0abb788987e35a66848692891f17f</gtr:id><gtr:otherNames>Baker DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>9FD88BC4575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D00EFA9-7FC5-448A-8500-3B4149856AF7</gtr:id><gtr:title>Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77053460c769d143610c0c1399cb41a2"><gtr:id>77053460c769d143610c0c1399cb41a2</gtr:id><gtr:otherNames>Alagaratnam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>pm_15409_29_23137282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81C741FC-BA84-47B7-9A84-940A2E1AE083</gtr:id><gtr:title>ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4843181f21764df7133f54d6d304065d"><gtr:id>4843181f21764df7133f54d6d304065d</gtr:id><gtr:otherNames>Hemberger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>fyz9v61ysHR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9A3C97E-6A63-4815-92A3-7E9F4006BC41</gtr:id><gtr:title>The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93977d2ba9fe935c99b3418690c14eaf"><gtr:id>93977d2ba9fe935c99b3418690c14eaf</gtr:id><gtr:otherNames>Canham MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cf1629e218f7.72348645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8DB333-9E99-4909-A305-6FBD35C2398B</gtr:id><gtr:title>High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c8b2fa7273856740f1dd6f4597cda0b"><gtr:id>8c8b2fa7273856740f1dd6f4597cda0b</gtr:id><gtr:otherNames>N?rv? E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>KLPfuCALao5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4618E312-9274-4389-9952-D569548491EE</gtr:id><gtr:title>A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID mice.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/866aeb2eb2f67561d4badd8e4fd0cf53"><gtr:id>866aeb2eb2f67561d4badd8e4fd0cf53</gtr:id><gtr:otherNames>Mohanty ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_15409_29_22367629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F0FF11B-35E5-49B8-80E1-42C2726A8396</gtr:id><gtr:title>PAX4 enhances beta-cell differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d35b264e78cb1334ae29357e5f8511b"><gtr:id>2d35b264e78cb1334ae29357e5f8511b</gtr:id><gtr:otherNames>Liew CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8F81FB5EEE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5622AE4A-67B2-4732-99ED-35943BD39ABD</gtr:id><gtr:title>Cancer genes hypermethylated in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/653c648f8ba3a9b096ce08aea0614090"><gtr:id>653c648f8ba3a9b096ce08aea0614090</gtr:id><gtr:otherNames>Calvanese V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>A1018A4CF37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4457DB87-6818-44D4-B44D-F8B58548B6AC</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>19769592124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3E17B45-9208-4A58-A1E5-B255ED828A88</gtr:id><gtr:title>Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3183d5f9359d778d60996f9b7461936"><gtr:id>d3183d5f9359d778d60996f9b7461936</gtr:id><gtr:otherNames>Sonne SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>7F66B5C598C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90F9868B-143A-4B9B-BA56-03689BAF2BC7</gtr:id><gtr:title>Expression of Syncytin 1 (HERV-W), in the preimplantation human blastocyst, embryonic stem cells and trophoblast cells derived in vitro.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f03dada251590b8cab08527f73f732"><gtr:id>62f03dada251590b8cab08527f73f732</gtr:id><gtr:otherNames>Soygur B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>585d37fe3e43f2.53581932</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801059</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>